Literature DB >> 15497680

Heat-treated Fungizone retains amphotericin B antifungal activity without renal toxicity in rats infected with Aspergillus fumigatus.

Olena Sivak1, Karen Bartlett, Kishor M Wasan.   

Abstract

PURPOSE: The purpose of this study was to assess the antifungal activity and renal and hepatic toxicity of amphotericin B (AmpB) following administration of Fungizone (FZ) and a heat-treated form of FZ (HFZ) to rats infected with Aspergillus fumigatus.
METHODS: Infected rats were administered FZ and HFZ at a dosing regimen of 1 mg/kg i.v. once daily for 4 consecutive days. Following administration the number of colony forming units (CFUs) of Aspergillus fumigatus in different organs and serum creatinine concentrations were determined.
RESULTS: FZ and HFZ had similar overall effectiveness in decreasing the total number of Aspergillus fumigatus CFUs found in all organs analyzed compared to controls. Except for the serum creatinine concentrations reported in the nontreated infected control rats, none of the treatment groups tested displayed a greater than 50% increase in serum creatinine.
CONCLUSIONS: Taken together, these findings suggest that HFZ at 1 mg/kg once daily x 4 days appears to be as effective as FZ as an antifungal agent without renal toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497680     DOI: 10.1023/b:pham.0000041449.46054.b4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol.

Authors:  K M Wasan; J S Conklin
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

2.  Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.

Authors:  M E Klepser; E J Wolfe; M A Pfaller
Journal:  J Antimicrob Chemother       Date:  1998-03       Impact factor: 5.790

3.  Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form.

Authors:  B Baas; K Kindt; A Scott; J Scott; P Mikulecky; S C Hartsel
Journal:  AAPS PharmSci       Date:  1999

Review 4.  Current role of therapy with amphotericin B.

Authors:  R D Meyer
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

5.  Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.

Authors:  Emmanuel Roilides; Caron A Lyman; Joanna Filioti; Onome Akpogheneta; Tin Sein; Cristina Gil Lamaignere; Ruta Petraitiene; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 6.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

7.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 8.  Amphotericin B and its delivery by liposomal and lipid formulations.

Authors:  C Gates; R J Pinney
Journal:  J Clin Pharm Ther       Date:  1993-06       Impact factor: 2.512

9.  Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion.

Authors:  K M Wasan; V B Grossie; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Influence of diet on experimental toxicity of amphotericin B deoxycholate.

Authors:  P Chavanet; V Joly; D Rigaud; J Bolard; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  3 in total

Review 1.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

2.  How can micelle systems be rebuilt by a heating process?

Authors:  Miguel Adelino da Silva-Filho; Scheyla Daniela Vieira da Silva Siqueira; Larissa Bandeira Freire; Ivonete Batista de Araújo; Káttya Gyselle de Holanda e Silva; Aldo da Cunha Medeiros; Irami Araújo-Filho; Anselmo Gomes de Oliveira; Eryvaldo Sócrates Tabosa do Egito
Journal:  Int J Nanomedicine       Date:  2012-01-12

Review 3.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.